{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:20:30Z","timestamp":1778700030009,"version":"3.51.4"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1097\/jcp.0b013e3182199bcc","type":"journal-article","created":{"date-parts":[[2011,4,20]],"date-time":"2011-04-20T07:10:53Z","timestamp":1303283453000},"page":"274-280","source":"Crossref","is-referenced-by-count":97,"title":["Sexual Dysfunction in First-Episode Schizophrenia Patients"],"prefix":"10.1097","volume":"31","author":[{"given":"Peter","family":"Malik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Kemmler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Hummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Riecher-Roessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 S.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Wolfgang","family":"Fleischhacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1055\/s-2007-981480","article-title":"Sexual dysfunction in psychiatric inpatients: the role of antipsychotic medication.","volume":"40","author":"Westheide","year":"2007","journal-title":"Pharmacopsychiatry"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1192\/bjp.182.1.50","article-title":"Nithsdale Schizophrenia Surveys 24: sexual dysfunction: case-control study.","volume":"182","author":"Macdonald","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"3","key":"R3-3-20210128","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v68n0302","article-title":"Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder.","volume":"68","author":"Howes","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"7","key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.eurpsy.2004.06.031","article-title":"Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence.","volume":"19","author":"Lambert","year":"2004","journal-title":"Eur Psychiatry"},{"issue":"3","key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4088\/JCP.v66n0309","article-title":"Male sexual dysfunction and quality of life in schizophrenia.","volume":"66","author":"Olfson","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.924","article-title":"Sexual dysfunction in schizophrenia: focus on recent evidence.","volume":"23","author":"Baggaley","year":"2008","journal-title":"Hum Psychopharmacol"},{"issue":"suppl 2","key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0306-4530(02)00130-0","article-title":"What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?","volume":"28","author":"Knegtering","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1185\/030079903125002865","article-title":"Hyperprolactinaemia and antipsychotic therapy in schizophrenia.","volume":"20","author":"Hummer","year":"2004","journal-title":"Curr Med Res Opin"},{"issue":"suppl 1","key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0306-4530(02)00113-0","article-title":"Sexual dysfunction and antipsychotic treatment.","volume":"28","author":"Cutler","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0306-3356(21)00235-1","article-title":"Endocrinology of sexual function.","volume":"7","author":"Bancroft","year":"1980","journal-title":"Clin Obstet Gynaecol"},{"issue":"2","key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/0269881107066333","article-title":"A naturalistic, 9-month follow-up, comparing olanzapine and conventional antipsychotics on sexual function and hormonal profile for males with schizophrenia.","volume":"21","author":"Costa","year":"2007","journal-title":"J Psychopharmacol"},{"issue":"7","key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1177\/0269881109106914","article-title":"A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia published online ahead of print October 13, 2009.","volume":"24","author":"Berwaerts","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"3","key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/archpsyc.1989.01810030081011","article-title":"Effects of psychotropic drugs on human erection and ejaculation.","volume":"46","author":"Segraves","year":"1989","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1111\/j.1743-6109.2010.01709.x","article-title":"Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics.","volume":"7","author":"Montejo","year":"2010","journal-title":"J Sex Med"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0165-1781(02)00123-3","article-title":"Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder.","volume":"111","author":"Canuso","year":"2002","journal-title":"Psychiatry Res"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1192\/bjp.181.1.49","article-title":"Sexual dysfunction in patients taking conventional antipsychotic medication.","volume":"181","author":"Smith","year":"2002","journal-title":"Br J Psychiatry"},{"key":"R18-3-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/01.jcp.0000106220.36344.04","article-title":"A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning.","volume":"24","author":"Knegtering","year":"2004","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"R19-3-20210128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.psyneuen.2008.02.008","article-title":"Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin?","volume":"33","author":"Knegtering","year":"2008","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/JCP.0b013e3181faf0e3","article-title":"Prolactin levels and sexual side effects in schizophrenia patients during antipsychotic treatment.","volume":"30","author":"Rettenbacher","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"R21-3-20210128","first-page":"137","article-title":"Sexual dysfunction in male schizophrenic patients.","volume":"56","author":"Aizenberg","year":"1995","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"e06","DOI":"10.4088\/JCP.7062br1c.e06","article-title":"Tolerability of antipsychotics: recent controversies and future management.","volume":"70","author":"Fleischhacker","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"2-3","key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2005.06.004","article-title":"EUFEST Steering Committee. The European First Episode Schizophrenia Trial (EUFEST): rationale and design of the trial.","volume":"78","author":"Fleischhacker","year":"2005","journal-title":"Schizophr Res"},{"issue":"9618","key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"EUFEST study group. Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1987.tb10566.x","article-title":"The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients.","volume":"334","author":"Lingjaerde","year":"1987","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"4","key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0447.1993.tb03366.x","article-title":"The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity.","volume":"87","author":"Gerlach","year":"1993","journal-title":"Acta Psychiatr Scand"},{"issue":"7","key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.psyneuen.2009.01.013","article-title":"Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone.","volume":"34","author":"van Bruggen","year":"2009","journal-title":"Psychoneuroendocrinology"},{"issue":"6","key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/01.jcp.0000186872.04984.56","article-title":"A 6-month prospective observational study on the effects of quetiapine on sexual functioning.","volume":"25","author":"Montejo Gonzalez","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-244X-8-95","article-title":"The effect of antipsychotic medication on sexual function and serum prolactin levels in community-treated schizophrenic patients: results from the Schizophrenia Trial of Aripiprazole (STAR) study (NCT00237913).","volume":"8","author":"Hanssens","year":"2008","journal-title":"BMC Psychiatry"},{"issue":"4","key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/YIC.0b013e3282f94905","article-title":"Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone.","volume":"23","author":"Rossi","year":"2008","journal-title":"Int Clin Psychopharmacol"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/JCP.0b013e31818501a1","article-title":"Changes in sexual function for outpatients with schizophrenia or other psychotic disorders treated with ziprasidone in clinical practice settings: a 3-month prospective, observational study.","volume":"28","author":"Montejo","year":"2008","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.eurpsy.2005.12.005","article-title":"Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.","volume":"21","author":"Dossenbach","year":"2006","journal-title":"Eur Psychiatry"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/00926230701866125","article-title":"Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders.","volume":"34","author":"Montejo","year":"2008","journal-title":"J Sex Marital Ther"},{"issue":"1","key":"R36-3-20210128","first-page":"13","article-title":"Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole published online ahead of print January 1, 2010.","volume":"38","author":"Montejo","year":"2010","journal-title":"Actas Esp Psiquiatr"},{"issue":"2","key":"R37-3-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00004850-200403000-00002","article-title":"A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.","volume":"9","author":"Mortimer","year":"2004","journal-title":"Int Clin Psychopharmacol"},{"issue":"suppl 1","key":"R38-3-20210128","first-page":"S84","article-title":"Galactorrhea due to psychotropic drugs.","volume":"37","author":"Kropp","year":"2004","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"R39-3-20210128","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1176\/ajp.156.4.631","article-title":"Sexual disturbances during clozapine and haloperidol treatment for schizophrenia.","volume":"56","author":"Hummer","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"7","key":"R40-3-20210128","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4088\/JCP.v62n07a07","article-title":"Comparison of sexual dysfunction in male schizophrenic patients maintained on treatment with classical antipsychotics versus clozapine.","volume":"62","author":"Aizenberg","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"1-2","key":"R41-3-20210128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0920-9964(01)00271-7","article-title":"Sexual side effects of novel antipsychotic medications.","volume":"56","author":"Wirshing","year":"2002","journal-title":"Schizophr Res"},{"issue":"1","key":"R42-3-20210128","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psyneuen.2008.08.015","article-title":"Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia.","volume":"34","author":"Konarzewska","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"R43-3-20210128","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/BF02190244","article-title":"Schizophrenia and oestrogens-is there an association?","volume":"242","author":"Riecher-Rossler","year":"1993","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"suppl 2","key":"R44-3-20210128","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.euroneuro.2008.02.004","article-title":"Prolactin awareness: an essential consideration for physical health in schizophrenia.","volume":"18","author":"Montejo","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"issue":"11-14","key":"R45-3-20210128","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1080\/00140130500101387","article-title":"Exercise thermoregulation and hyperprolactinemia.","volume":"48","author":"Low","year":"2005","journal-title":"Ergonomics"},{"issue":"1-3","key":"R46-3-20210128","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.schres.2007.04.033","article-title":"Sexual functioning, psychopathology and quality of life in patients with schizophrenia.","volume":"94","author":"Fan","year":"2007","journal-title":"Schizophr Res"},{"issue":"12","key":"R47-3-20210128","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1743-6109.2008.00859.x","article-title":"Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.","volume":"5","author":"Westheide","year":"2008","journal-title":"J Sex Med"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004714-201106000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T11:28:28Z","timestamp":1686050908000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201106000-00003"}},"subtitle":["Results From European First Episode Schizophrenia Trial"],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e3182199bcc","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}